Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Advances in Therapy
|
April 28, 2025
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
Piotr Wiland, Charlotte Both, Norman B Gaylis, et al.
The Journal of Rheumatology
|
March 3, 2010
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial
Philip J Mease, Stanley Cohen, Norman B Gaylis, et al.
BMC Musculoskeletal Disorders
|
June 3, 2014
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study
Charles H Pritchard, Maria W Greenwald, Joel M Kremer, et al.
Rheumatology (Oxford, England)
|
September 20, 2011
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis
Paul Emery, Philip J Mease, Andrea Rubbert-Roth, et al.
The Lancet. Rheumatology
|
January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study
Mark C Genovese, Norman B Gaylis, David Sikes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2022
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome
Norman B Gaylis, Angela Ritter, Scott A Kelly, et al.
The Journal of Rheumatology
|
September 3, 2011
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience
Charles G Peterfy, Peter Countryman, Annarita Gabriele, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
September 1, 2010
Preprinted standardized orders promote venous thromboembolism prophylaxis compared with traditional handwritten orders: an endorsement of standardized evidence-based practice
Franklin D Gaylis, Sothary J Van, Michael A Daneshvar, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 29, 2020
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study
Piotr Wiland, Sławomir Jeka, Eva Dokoupilová, et al.
Nature Medicine
|
December 22, 2025
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
John R P Tesser, Angela R Crowley, Emily Jane Box, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Advances in Therapy
|
April 28, 2025
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
Piotr Wiland, Charlotte Both, Norman B Gaylis, et al.
The Journal of Rheumatology
|
March 3, 2010
Efficacy and safety of retreatment in patients with rheumatoid arthritis with previous inadequate response to tumor necrosis factor inhibitors: results from the SUNRISE trial
Philip J Mease, Stanley Cohen, Norman B Gaylis, et al.
BMC Musculoskeletal Disorders
|
June 3, 2014
Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study
Charles H Pritchard, Maria W Greenwald, Joel M Kremer, et al.
Rheumatology (Oxford, England)
|
September 20, 2011
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis
Paul Emery, Philip J Mease, Andrea Rubbert-Roth, et al.
The Lancet. Rheumatology
|
January 26, 2024
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study
Mark C Genovese, Norman B Gaylis, David Sikes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 22, 2022
Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome
Norman B Gaylis, Angela Ritter, Scott A Kelly, et al.
The Journal of Rheumatology
|
September 3, 2011
Magnetic resonance imaging in rheumatoid arthritis clinical trials: emerging patterns based on recent experience
Charles G Peterfy, Peter Countryman, Annarita Gabriele, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
September 1, 2010
Preprinted standardized orders promote venous thromboembolism prophylaxis compared with traditional handwritten orders: an endorsement of standardized evidence-based practice
Franklin D Gaylis, Sothary J Van, Michael A Daneshvar, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 29, 2020
Switching to Biosimilar SDZ-ADL in Patients with Moderate-to-Severe Active Rheumatoid Arthritis: 48-Week Efficacy, Safety and Immunogenicity Results From the Phase III, Randomized, Double-Blind ADMYRA Study
Piotr Wiland, Sławomir Jeka, Eva Dokoupilová, et al.
Nature Medicine
|
December 22, 2025
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
John R P Tesser, Angela R Crowley, Emily Jane Box, et al.
Page
of 3